1. Home
  2. TNYA vs OSUR Comparison

TNYA vs OSUR Comparison

Compare TNYA & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.79

Market Cap

178.5M

Sector

Health Care

ML Signal

HOLD

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$3.20

Market Cap

214.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNYA
OSUR
Founded
2016
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.5M
214.1M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
TNYA
OSUR
Price
$0.79
$3.20
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$5.33
$3.00
AVG Volume (30 Days)
2.8M
400.1K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
54.96
N/A
EPS
N/A
N/A
Revenue
N/A
$167,064,000.00
Revenue This Year
N/A
$4.48
Revenue Next Year
N/A
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$2.08
52 Week High
$2.35
$3.76

Technical Indicators

Market Signals
Indicator
TNYA
OSUR
Relative Strength Index (RSI) 56.66 58.88
Support Level $0.64 $3.10
Resistance Level $0.82 $3.25
Average True Range (ATR) 0.05 0.12
MACD 0.01 0.01
Stochastic Oscillator 87.27 85.38

Price Performance

Historical Comparison
TNYA
OSUR

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Share on Social Networks: